Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata
Completed · Not applicable
Conditions studied: Alopecia Areata
In brief
This is a single center, randomized, investigator-masked study to determine the efficacy and safety of latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients who have lost their eyelashes due to alopecia areata. These medications are FDA-approved as eyedrops for patients with glaucoma who have been noted to grow longer, darker, and thicker eyelashes with their use. In this study, patients will be asked to apply these solutions to the affected eyelid margins of one eye with a sterile cotton-tipped applicator once a day.
Key facts
- Study ID
- NCT00187577
- Run by
- University of California, San Francisco
- People needed
- 14
- Starts
- 2005-06-01
- Expected to finish
- 2006-03-01
- Last updated by the study team
- 2011-06-09
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Males and females in good general health, ages 18-70.
- Patients with alopecia areata who have had 50% or more eyelash loss for 6 months or longer.
You may not qualify if…
- Any pre-existing eye disorder that would preclude use of a topical agent around the eyes (e.g. infection, inflammation, recent surgery.)
- Subjects with limited close vision who cannot see their eyelid margin clearly.
- Immunosuppressed state.
- Women who are pregnant or who are trying to become pregnant, or are breast-feeding.
- Patients with known allergy to latanoprost or bimatoprost, other prostaglandin F-2a or related drugs, or to benzalkonium.
- Unable to read or follow instructions.
Where it is running
- University of California, San Francisco — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.